Menu
GeneBe

rs8176331

Variant summary

Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000468682.2(HRAS):c.-54+1070G>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.24 in 151,792 control chromosomes in the GnomAD database, including 4,764 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.24 ( 4764 hom., cov: 33)

Consequence

HRAS
ENST00000468682.2 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.87
Variant links:
Genes affected
HRAS (HGNC:5173): (HRas proto-oncogene, GTPase) This gene belongs to the Ras oncogene family, whose members are related to the transforming genes of mammalian sarcoma retroviruses. The products encoded by these genes function in signal transduction pathways. These proteins can bind GTP and GDP, and they have intrinsic GTPase activity. This protein undergoes a continuous cycle of de- and re-palmitoylation, which regulates its rapid exchange between the plasma membrane and the Golgi apparatus. Mutations in this gene cause Costello syndrome, a disease characterized by increased growth at the prenatal stage, growth deficiency at the postnatal stage, predisposition to tumor formation, cognitive disability, skin and musculoskeletal abnormalities, distinctive facial appearance and cardiovascular abnormalities. Defects in this gene are implicated in a variety of cancers, including bladder cancer, follicular thyroid cancer, and oral squamous cell carcinoma. Multiple transcript variants, which encode different isoforms, have been identified for this gene. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.7).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.335 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
LRRC56XM_011519875.3 linkuse as main transcriptc.-424-2815C>A intron_variant
LRRC56XM_011519877.3 linkuse as main transcriptc.-161-3797C>A intron_variant
LRRC56XM_017017167.2 linkuse as main transcriptc.-499-2740C>A intron_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
HRASENST00000468682.2 linkuse as main transcriptc.-54+1070G>T intron_variant 3
HRASENST00000462734.2 linkuse as main transcriptc.-54+553G>T intron_variant, NMD_transcript_variant 2

Frequencies

GnomAD3 genomes
AF:
0.240
AC:
36365
AN:
151684
Hom.:
4753
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.340
Gnomad AMI
AF:
0.267
Gnomad AMR
AF:
0.184
Gnomad ASJ
AF:
0.167
Gnomad EAS
AF:
0.184
Gnomad SAS
AF:
0.215
Gnomad FIN
AF:
0.178
Gnomad MID
AF:
0.245
Gnomad NFE
AF:
0.211
Gnomad OTH
AF:
0.227
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.240
AC:
36401
AN:
151792
Hom.:
4764
Cov.:
33
AF XY:
0.238
AC XY:
17694
AN XY:
74198
show subpopulations
Gnomad4 AFR
AF:
0.340
Gnomad4 AMR
AF:
0.184
Gnomad4 ASJ
AF:
0.167
Gnomad4 EAS
AF:
0.184
Gnomad4 SAS
AF:
0.215
Gnomad4 FIN
AF:
0.178
Gnomad4 NFE
AF:
0.211
Gnomad4 OTH
AF:
0.231
Alfa
AF:
0.106
Hom.:
159
Bravo
AF:
0.242
Asia WGS
AF:
0.212
AC:
733
AN:
3464

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.70
Cadd
Benign
5.7
Dann
Benign
0.50

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs8176331; hg19: chr11-535783; API